Alzheimer's Disease-Associated Cognitive Disabilities
暫譯: 阿茲海默症相關的認知障礙

Dr. Moumita Kundu is currently working as an Associate Professor in the Department of Pharmaceutical Technology at Brainware University, West Bengal. She is also a member of the Center for Multidisciplinary Research & Innovations at Brainware University. Her research focuses on disease biology and therapeutics. She is a former Research Associate at KIIT Deemed University, Bhubaneswar. Dr. Kundu earned her PhD from the Indian Institute of Technology Kharagpur, West Bengal, India. She completed her B.Pharm and M.Pharm at Jadavpur University, West Bengal, where she received the University Gold Medal for securing the first position in order of merit in the B.Pharm examination of 2013. She also has expertise in stimuli-responsive drug delivery system development and bioanalytical method development. Dr. Kundu has published several SCI(E) articles in reputed international journals, including Molecular Cancer, BBA-Reviews on Cancer, BBA-Molecular Basis of Disease, Experimental Cell Research, and Chemical Engineering Journal, achieving an h-index of 14.

Dr. Subhayan Das is a medical practitioner with expertise in cancer biology, biomedical engineering, and clinical research. He has obtained his Bachelor's degree in Medical Sciences from NRS Medical College & Hospital, a Master's degree in Biomedical Engineering, and a Doctorate degree in Cancer Biology from the Indian Institute of Technology Kharagpur. He is currently an Associate Professor at Brainware University in the Department of Allied Health Sciences. He has more than 15 years of experience in clinics and 5 years of experience in translational health research. His research is focused on breast cancer stem cells, chemoresistance, computational biology, and drug design. Dr. Das is highly proficient in elucidating the molecular mechanisms of breast cancer stem cells and chemoresistance and in discovering molecular targets for novel anti-cancer therapies. He has also made significant contributions to the development of smart biomaterials for wound healing and anti-cancer drug delivery systems. He has an impressive h-index of 25, and his publications in high-impact journals such as PNAS, Cancer Letters, Oncogene, BBA - Molecular Basis of Disease, and Biochemical Pharmacology, among others, are a testament to his remarkable accomplishments.

穆米塔·昆杜博士目前擔任西孟加拉邦Brainware大學藥物技術系的副教授。她同時也是Brainware大學多學科研究與創新中心的成員。她的研究專注於疾病生物學和治療學。昆杜博士曾擔任基特理工學院（KIIT）德定大學的研究助理。她在印度西孟加拉邦的印度理工學院卡哈爾古爾獲得博士學位。她在西孟加拉邦的賈達夫普爾大學完成了藥學學士（B.Pharm）和藥學碩士（M.Pharm）學位，並因在2013年B.Pharm考試中獲得第一名而獲得大學金獎。她在刺激響應藥物傳遞系統開發和生物分析方法開發方面也具有專業知識。昆杜博士在多個知名國際期刊上發表了數篇SCI(E)文章，包括《分子癌症》（Molecular Cancer）、《癌症評論》（BBA-Reviews on Cancer）、《疾病的分子基礎》（BBA-Molecular Basis of Disease）、《實驗細胞研究》（Experimental Cell Research）和《化學工程期刊》（Chemical Engineering Journal），其h指數達到14。

蘇巴揚·達斯博士是一位醫學專家，專長於癌症生物學、生物醫學工程和臨床研究。他在NRS醫學院及醫院獲得醫學科學學士學位，並在印度理工學院卡哈爾古爾獲得生物醫學工程碩士學位和癌症生物學博士學位。目前，他是Brainware大學聯合健康科學系的副教授。他在臨床工作方面擁有超過15年的經驗，並在轉化健康研究方面擁有5年的經驗。他的研究專注於乳腺癌幹細胞、化學耐藥性、計算生物學和藥物設計。達斯博士在闡明乳腺癌幹細胞和化學耐藥性的分子機制以及發現新型抗癌療法的分子靶點方面具有高度專業能力。他在傷口癒合和抗癌藥物傳遞系統的智能生物材料開發方面也做出了重要貢獻。他的h指數達到25，並在《美國國家科學院院刊》（PNAS）、《癌症信函》（Cancer Letters）、《癌基因》（Oncogene）、《疾病的分子基礎》（BBA-Molecular Basis of Disease）和《生化藥理學》（Biochemical Pharmacology）等高影響力期刊上發表的文章，充分證明了他的卓越成就。